| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |